Longboard Pharmaceuticals financials at a glance

The revenue of Longboard Pharmaceuticals is reported as 0 billion Dollars in the fiscal year 2023. The earnings were -2.56 Dollars per share in 2023, which was 32.64 lower than 2021. And about -0.03808 billion Dollars are reported as free cash flow in the financials of Longboard Pharmaceuticals 2023. No dividends were paid to the shareholders of the Longboard Pharmaceuticals stock NasdaqGM:LBPH in the financial year 2023.